Northern Trust’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-109,732
| Closed | -$2.08M | – | 4358 |
|
|
2019
Q1 | $2.08M | Sell |
109,732
-1,074
| -1% | -$17.4K | ﹤0.01% | 3060 |
|
|
2018
Q4 | $1.5M | Buy |
110,806
+20,201
| +22% | +$226K | ﹤0.01% | 3200 |
|
|
2018
Q3 | $1.01M | Buy |
+90,605
| New | +$907K | ﹤0.01% | 3469 |
|
|
2017
Q1 | – | Sell |
-237,415
| Closed | -$1.17M | – | 4340 |
|
|
2016
Q4 | $1.17M | Sell |
237,415
-2,255
| -0.9% | -$11.5K | ﹤0.01% | 3302 |
|
|
2016
Q3 | $1.19M | Sell |
239,670
-5,513
| -2% | -$28.2K | ﹤0.01% | 3292 |
|
|
2016
Q2 | $1.25M | Buy |
245,183
+1,845
| +0.8% | +$9.94K | ﹤0.01% | 3278 |
|
|
2016
Q1 | $1.39M | Sell |
243,338
-202
| -0.1% | -$1.41K | ﹤0.01% | 3144 |
|
|
2015
Q4 | $2.53M | Sell |
243,540
-11,777
| -5% | -$160K | ﹤0.01% | 2908 |
|
|
2015
Q3 | $4.72M | Buy |
255,317
+2,910
| +1% | +$56.2K | ﹤0.01% | 2478 |
|
|
2015
Q2 | $4.91M | Buy |
252,407
+15,904
| +7% | +$281K | ﹤0.01% | 2528 |
|
|
2015
Q1 | $4.16M | Sell |
236,503
-7,983
| -3% | -$134K | ﹤0.01% | 2623 |
|
|
2014
Q4 | $3.91M | Buy |
244,486
+13,126
| +6% | +$176K | ﹤0.01% | 2659 |
|
|
2014
Q3 | $2.91M | Buy |
231,360
+7,176
| +3% | +$102K | ﹤0.01% | 2852 |
|
|
2014
Q2 | $3.5M | Sell |
224,184
-21,279
| -9% | -$313K | ﹤0.01% | 2762 |
|
|
2014
Q1 | $3.22M | Sell |
245,463
-9,371
| -4% | -$147K | ﹤0.01% | 2843 |
|
|
2013
Q4 | $4.1M | Buy |
254,834
+6,895
| +3% | +$110K | ﹤0.01% | 2695 |
|
|
2013
Q3 | $4.13M | Sell |
247,939
-18,204
| -7% | -$269K | ﹤0.01% | 2645 |
|
|
2013
Q2 | $2.68M | Buy |
+266,143
| New | +$2.8M | ﹤0.01% | 2803 |
|
Other funds holding OSIR
Northern Trust's OSIR Position: Q2 2019 in Review
Northern Trust sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 109,732 shares — an estimated $2.08M sold.
Northern Trust first reported a position in OSIR in Q2 2013 and held it in 18 quarters. The position peaked at $4.91M in Q2 2015. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.
- Northern Trust reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
- Northern Trust sold 109,732 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $2.08M.
- Northern Trust first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 18 quarters.
- Northern Trust's Osiris Therapeutics, Inc. Common Stock position peaked at $4.91M in Q2 2015.
- 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.
Based on Northern Trust's 13F filing for Q2 2019, filed 13 Aug 2019.